Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription


3 AJR Am J Roentgenol
1 Am J Pathol
1 Am J Surg
3 Ann Oncol
1 Ann Surg
4 Ann Surg Oncol
2 Anticancer Res
4 BMC Cancer
2 Br J Cancer
2 Breast Cancer
3 Breast Cancer Res
7 Breast Cancer Res Treat
1 Breast J
1 Cancer Chemother Pharmacol
2 Cancer Epidemiol Biomarkers Prev
8 Cancer Res
5 Clin Breast Cancer
2 Clin Cancer Res
6 Eur J Surg Oncol
2 Eur Radiol
3 Int J Cancer
6 Int J Radiat Oncol Biol Phys
1 J Biol Chem
4 J Clin Oncol
1 J Surg Oncol
3 Lancet Oncol
1 Mod Pathol
1 Nat Rev Clin Oncol
11 NPJ Breast Cancer
2 Oncogene
1 Oncology (Williston Park)
1 PLoS Comput Biol
8 PLoS One
2 Proc Natl Acad Sci U S A
2 Radiol Imaging Cancer
2 Radiology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    AJR Am J Roentgenol

  1. RAUSCHER GH, Murphy AM, Qiu Q, Dolecek TA, et al
    The "Sweet Spot" Revisited: Optimal Recall Rates for Cancer Detection With 2D and 3D Digital Screening Mammography in the Metro Chicago Breast Cancer Registry.
    AJR Am J Roentgenol. 2021 Feb 10:1-9. doi: 10.2214/AJR.19.22429.
    PubMed         Abstract available

  2. FORERO PA, Jimenez GP, Enciso JR
    Differentiating Benign Lesions From Areas of Malignant Nonmass Enhancement With MRI.
    AJR Am J Roentgenol. 2021;216:W7.

  3. MORI N, Sheth D, Abe H
    Reply to "Differentiating Benign Lesions From Areas of Malignant Nonmass Enhancement With MRI".
    AJR Am J Roentgenol. 2021;216:W8.

    Am J Pathol

  4. ANWAR T, Gonzalez ME, Kleer CG
    Non-canonical functions of the Polycomb group protein EZH2 in breast cancer.
    Am J Pathol. 2021 Feb 5. pii: S0002-9440(21)00044.
    PubMed         Abstract available

    Am J Surg

  5. ABEL MK, Brabham CE, Guo R, Fahrner-Scott K, et al
    Breast conservation therapy versus mastectomy in the surgical management of invasive lobular carcinoma measuring 4 cm or greater.
    Am J Surg. 2021;221:32-36.
    PubMed         Abstract available

    Ann Oncol

  6. VANACKER H, Cassier PA, Bachelot T
    The complex balance of PI3K inhibition.
    Ann Oncol. 2021;32:127-128.

  7. AGOSTINETTO E, Ignatiadis M
    Optimal treatment for aromatase inhibitor-resistant metastatic breast cancer patients: Lessons from the PEARL study.
    Ann Oncol. 2021 Feb 8. pii: S0923-7534(21)00106.

  8. MATIKAS A, Foukakis T
    SOLAR1s: alpelisib returns to earth?
    Ann Oncol. 2021;32:129-132.

    Ann Surg

    Commentary on "Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk".
    Ann Surg. 2020;272:410.

    Ann Surg Oncol

  10. CORSO G
    ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field.
    Ann Surg Oncol. 2020;27:1875-1876.

  11. NERON M, Firmin N
    ASO Author Reflections: How Far Should We Go in Local Management for a Localized Malignant Phyllodes Tumor of the Breast?
    Ann Surg Oncol. 2020;27:1828-1829.

  12. SORAN A, Dogan L, Ozbas S
    ASO Author Reflections: Locoregional Therapy in De Novo Bone-Only Metastatic Breast Cancer Provides Survival Advantage Regardless of Therapy Sequencing.
    Ann Surg Oncol. 2021 Feb 5. pii: 10.1245/s10434-021-09664.

  13. MINAMI C, Pilewskie ML
    ASO Author Reflections: Conceptualizing Risk in Women with Lobular Carcinoma In Situ.
    Ann Surg Oncol. 2020;27:1852-1853.

    Anticancer Res

  14. UNGER J, Rutkowski R, Kohlmann T, Paepke S, et al
    Potential Risk Factors Influencing the Formation of Postoperative Seroma After Breast Surgery - A Prospective Study.
    Anticancer Res. 2021;41:859-867.
    PubMed         Abstract available

  15. WALKER RR, Gallegos KM, Bratton MR, Lemieux KP, et al
    Acquisition of Letrozole Resistance Through Activation of the p38/MAPK Signaling Cascade.
    Anticancer Res. 2021;41:583-599.
    PubMed         Abstract available

    BMC Cancer

  16. LIU M, Liu S, Yang L, Wang S, et al
    Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:118.
    PubMed         Abstract available

  17. PENG C, DuPre N, VoPham T, Heng YJ, et al
    Low dose environmental radon exposure and breast tumor gene expression.
    BMC Cancer. 2020;20:695.
    PubMed         Abstract available

  18. TAN W, Liu M, Wang L, Guo Y, et al
    Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.
    BMC Cancer. 2021;21:126.
    PubMed         Abstract available

  19. JIANG H, Li H
    Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
    BMC Cancer. 2021;21:149.
    PubMed         Abstract available

    Br J Cancer

  20. LAAS E, Labrosse J, Hamy AS, Benchimol G, et al
    Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore.
    Br J Cancer. 2021 Feb 9. pii: 10.1038/s41416-020-01251.
    PubMed         Abstract available

  21. BRUNELLE CL, Taghian AG
    Lymphoedema screening: setting the standard.
    Br J Cancer. 2020;123:1-2.
    PubMed         Abstract available

    Breast Cancer

  22. ZHANG Y, Tian J, Qu C, Peng Y, et al
    Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cells.
    Breast Cancer. 2021 Feb 10. pii: 10.1007/s12282-021-01221.
    PubMed         Abstract available

  23. OCHI T, Tsunoda H, Matsuda N, Nozaki F, et al
    Accuracy of morphologic change measurements by ultrasound in predicting pathological response to neoadjuvant chemotherapy in triple-negative and HER2-positive breast cancer.
    Breast Cancer. 2021 Feb 9. pii: 10.1007/s12282-021-01220.
    PubMed         Abstract available

    Breast Cancer Res

  24. GILMORE N, Mohile S, Lei L, Culakova E, et al
    The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy.
    Breast Cancer Res. 2021;23:19.
    PubMed         Abstract available

  25. SHANG L, Hattori M, Fleming G, Jaskowiak N, et al
    Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients.
    Breast Cancer Res. 2021;23:18.
    PubMed         Abstract available

  26. AINE M, Boyaci C, Hartman J, Hakkinen J, et al
    Molecular analyses of triple-negative breast cancer in the young and elderly.
    Breast Cancer Res. 2021;23:20.
    PubMed         Abstract available

    Breast Cancer Res Treat

  27. NAOUM GE, Oladeru OT, Niemierko A, Salama L, et al
    Optimal breast reconstruction type for patients treated with neoadjuvant chemotherapy, mastectomy followed by radiation therapy.
    Breast Cancer Res Treat. 2020;183:127-136.
    PubMed         Abstract available

  28. LIU D
    Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
    Breast Cancer Res Treat. 2020;183:95-105.
    PubMed         Abstract available

  29. LEEVAN E, Ho BT, Seto S, Shen J, et al
    Use of MarginProbe as an adjunct to standard operating procedure does not significantly reduce re-excision rates in breast conserving surgery.
    Breast Cancer Res Treat. 2020;183:145-151.
    PubMed         Abstract available

  30. DA SILVA LR, de Andrade CA, Brenelli F, Ramalho S, et al
    Real-world data on neoadjuvant endocrine therapy in ER-positive/HER2-negative breast cancer.
    Breast Cancer Res Treat. 2021 Feb 4. pii: 10.1007/s10549-020-06076.
    PubMed         Abstract available

  31. COLETTA AM, Agha NH, Baker FL, Niemiro GM, et al
    The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer.
    Breast Cancer Res Treat. 2021 Feb 8. pii: 10.1007/s10549-021-06111.
    PubMed         Abstract available

  32. LIU M, Xie F, Liu M, Zhang Y, et al
    Association between BRCA mutational status and survival in patients with breast cancer: a systematic review and meta-analysis.
    Breast Cancer Res Treat. 2021 Feb 9. pii: 10.1007/s10549-021-06104.
    PubMed         Abstract available

  33. PEATE M, Saunders C, Cohen P, Hickey M, et al
    Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors.
    Breast Cancer Res Treat. 2021 Feb 11. pii: 10.1007/s10549-021-06117.
    PubMed         Abstract available

    Breast J

  34. KANANA N, Ben David MA, Nissan N, Yagil Y, et al
    Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.
    Breast J. 2021 Feb 11. doi: 10.1111/tbj.14190.
    PubMed         Abstract available

    Cancer Chemother Pharmacol

  35. YI X, Lou L, Wang J, Xiong J, et al
    Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway.
    Cancer Chemother Pharmacol. 2021 Feb 5. pii: 10.1007/s00280-021-04238.
    PubMed         Abstract available

    Cancer Epidemiol Biomarkers Prev

    Diet and Prognosis in Women with Breast Cancer.
    Cancer Epidemiol Biomarkers Prev. 2021;30:252-254.
    PubMed         Abstract available

  37. TASTULA A, Jukkola A, Alakokkare AE, Nordstrom T, et al
    Early-life risk factors for breast cancer - prospective follow-up in the Northern Finland Birth Cohort 1966.
    Cancer Epidemiol Biomarkers Prev. 2021 Feb 9. pii: 1055-9965.EPI-20-1442.
    PubMed         Abstract available

    Cancer Res

  38. CHAMBERLIN T, Clack M, Silvers C, Kuziel G, et al
    Targeting Obesity-Induced Macrophages during Preneoplastic Growth Promotes Mammary Epithelial Stem/Progenitor Activity, DNA Damage, and Tumor Formation.
    Cancer Res. 2020;80:4465-4475.
    PubMed         Abstract available

  39. YANG C, Wu J, Liu X, Wang Y, et al
    Circadian Rhythm Is Disrupted by ZNF704 in Breast Carcinogenesis.
    Cancer Res. 2020;80:4114-4128.
    PubMed         Abstract available

  40. LAUKO A, Mu Z, Gutmann DH, Naik UP, et al
    Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression.
    Cancer Res. 2020;80:4878-4885.
    PubMed         Abstract available

  41. KIMMEL GJ, Dane M, Heiser LM, Altrock PM, et al
    Integrating Mathematical Modeling with High-Throughput Imaging Explains How Polyploid Populations Behave in Nutrient-Sparse Environments.
    Cancer Res. 2020;80:5109-5120.
    PubMed         Abstract available

  42. SOOTOME H, Fujita H, Ito K, Ochiiwa H, et al
    Futibatinib Is a Novel Irreversible FGFR 1-4 Inhibitor That Shows Selective Antitumor Activity against FGFR-Deregulated Tumors.
    Cancer Res. 2020;80:4986-4997.
    PubMed         Abstract available

  43. ANLAS AA, Nelson CM
    Soft Microenvironments Induce Chemoresistance by Increasing Autophagy Downstream of Integrin-Linked Kinase.
    Cancer Res. 2020;80:4103-4113.
    PubMed         Abstract available

  44. MAMO M, Ye IC, DiGiacomo JW, Park JY, et al
    Hypoxia Alters the Response to Anti-EGFR Therapy by Regulating EGFR Expression and Downstream Signaling in a DNA Methylation-Specific and HIF-Dependent Manner.
    Cancer Res. 2020;80:4998-5010.
    PubMed         Abstract available

  45. QUINN HM, Vogel R, Popp O, Mertins P, et al
    YAP and beta-catenin cooperate to drive oncogenesis in basal breast cancer.
    Cancer Res. 2021 Feb 11. pii: 0008-5472.CAN-20-2801.
    PubMed         Abstract available

    Clin Breast Cancer

  46. SEFIDBAKHT S, Askarian M, Bijan B, Eghtedari M, et al
    Resuming Breast Imaging Services in the Aftermath of the COVID-19 Pandemic: Safety and Beyond.
    Clin Breast Cancer. 2021;21:e136-e140.
    PubMed         Abstract available

  47. PADMALATHA S, Tsai YT, Ku HC, Wu YL, et al
    Higher Risk of Depression After Total Mastectomy Versus Breast Reconstruction Among Adult Women With Breast Cancer: A Systematic Review and Metaregression.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00004.
    PubMed         Abstract available

  48. MARTIN HUERTAS R, Fernandez Abad M, Corral de la Fuente E, Serrano Domingo JJ, et al
    Prolonged Responses With Trastuzumab Emtasine Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer Refractory to Trastuzumab and Pertuzumab: Systematic Review of Evidence.
    Clin Breast Cancer. 2021 Jan 7. pii: S1526-8209(21)00005.
    PubMed         Abstract available

  49. CHEN X, Wang J, Fan Y, Luo Y, et al
    Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
    Clin Breast Cancer. 2020 Dec 16. pii: S1526-8209(20)30218.
    PubMed         Abstract available

  50. CHEN P, Chen R, Guo H, Cheng J, et al
    CASC15 Polymorphisms are Correlated With Breast Cancer Susceptibility in Chinese Han Women.
    Clin Breast Cancer. 2021 Jan 6. pii: S1526-8209(21)00006.
    PubMed         Abstract available

    Clin Cancer Res

  51. WANG X, Veeraraghavan J, Liu CC, Cao X, et al
    Therapeutic targeting of nemo-like kinase in primary and acquired endocrine-resistant breast cancer.
    Clin Cancer Res. 2021 Feb 4. pii: 1078-0432.CCR-20-2961.
    PubMed         Abstract available

  52. EDLUND K, Madjar K, Lebrecht A, Aktas B, et al
    Gene expression-based prediction of neoadjuvant chemotherapy response in early breast cancer: results of the prospective multicenter EXPRESSION trial.
    Clin Cancer Res. 2021 Feb 4. pii: 1078-0432.CCR-20-2662.
    PubMed         Abstract available

    Eur J Surg Oncol

  53. PILGER TL, Francisco DF, Candido Dos Reis FJ
    Effect of sentinel lymph node biopsy on upper limb function in women with early breast cancer: A systematic review of clinical trials.
    Eur J Surg Oncol. 2021 Jan 30. pii: S0748-7983(21)00054.
    PubMed         Abstract available

  54. KIM YA, Kim YA, Cho SW, Song YS, et al
    Increased expression of thyroid hormone receptor alpha and estrogen receptor alpha in breast cancer associated with thyroid cancer.
    Eur J Surg Oncol. 2021 Jan 22. pii: S0748-7983(21)00042.
    PubMed         Abstract available

  55. VAN BEKKUM S, Ter Braak BPM, Plaisier PW, van Rosmalen J, et al
    Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

  56. GODDEN AR, Wood SH, James SE, MacNeill FA, et al
    A scoring system for 3D surface images of breast reconstruction developed using the Delphi consensus process.
    Eur J Surg Oncol. 2020;46:1580-1587.
    PubMed         Abstract available

  57. MANDISH SF, Gaskins JT, Yusuf MB, Little BP, et al
    Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care, and overall survival.
    Eur J Surg Oncol. 2020;46:1596-1604.
    PubMed         Abstract available

  58. UNUKOVYCH D, Gumuscu R, Warnberg F, de Boniface J, et al
    Breast reconstruction patterns from a Swedish nation-wide survey.
    Eur J Surg Oncol. 2020;46.
    PubMed         Abstract available

    Eur Radiol

  59. SARDANELLI F, Trimboli RM, Houssami N, Gilbert FJ, et al
    Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study.
    Eur Radiol. 2020;30:5427-5436.
    PubMed         Abstract available

  60. ZHANG X, Yang Z, Cui W, Zheng C, et al
    Preoperative prediction of axillary sentinel lymph node burden with multiparametric MRI-based radiomics nomogram in early-stage breast cancer.
    Eur Radiol. 2021 Feb 10. pii: 10.1007/s00330-020-07674.
    PubMed         Abstract available

    Int J Cancer

  61. WATT GP, John EM, Bandera EV, Malone KE, et al
    Race, Ethnicity and Risk of Second Primary Contralateral Breast Cancer in the United States.
    Int J Cancer. 2021 Feb 5. doi: 10.1002/ijc.33501.
    PubMed         Abstract available

  62. ARTHUR RS, Dannenberg AJ, Rohan TE
    The association of prediagnostic circulating levels of cardiometabolic markers, testosterone and SHBG with risk of breast cancer among normal weight postmenopausal women in the UK Biobank.
    Int J Cancer. 2021 Feb 10. doi: 10.1002/ijc.33508.
    PubMed         Abstract available

  63. ELGHAZALY H, Aref AT, Anderson BO, Arun B, et al
    The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low- and middle-income countries and the MENA Region.
    Int J Cancer. 2021 Feb 9. doi: 10.1002/ijc.33506.
    PubMed         Abstract available

    Int J Radiat Oncol Biol Phys

  64. LAUCIS AM, Jagsi R, Griffith KA, Dominello MM, et al
    The Role of Facility Variation on Racial Disparities in Use of Hypofractionated Whole Breast Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:949-958.
    PubMed         Abstract available

    The Local Control of Systemic Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:233-234.

  66. MCDUFF SGR, Bellon JR, Shannon KM, Gadd MA, et al
    ATM Variants in Breast Cancer: Implications for Breast Radiotherapy Treatment Recommendations.
    Int J Radiat Oncol Biol Phys. 2021 Feb 2. pii: S0360-3016(21)00119.
    PubMed         Abstract available

  67. HARA JH, Son CH
    From Chemo Rejection to Regional Radiation: A Post-Mastectomy Dilemma.
    Int J Radiat Oncol Biol Phys. 2020;107:232.

    Extensive Lymphovascular Invasion Warrants Extensive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:234-235.

  69. SHAH C, Vicini F
    Early Stage, But Not So Routine.
    Int J Radiat Oncol Biol Phys. 2020;107:233.

    J Biol Chem

  70. EVANGELINE KANG TZ, Zhu L, Yang D, Ding D, et al
    The elevated transcription of ADAM19 by the oncohistone H2BE76K contributes to oncogenic properties in breast cancer.
    J Biol Chem. 2021 Feb 3:100374. doi: 10.1016/j.jbc.2021.100374.
    PubMed         Abstract available

    J Clin Oncol

  71. ROMERO M, Melo A, Bedoya N, de la Hoz J, et al
    Should Flow Cytometry Be Considered a First Line of Study in the Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma?
    J Clin Oncol. 2020 Jun 17:JCO2000712. doi: 10.1200/JCO.20.00712.

  72. TUNG N, Hacker MR, Garber JE
    Reply to S. Takamizawa et al.
    J Clin Oncol. 2020;38:2700-2701.

  73. JAFFE ES, Feldman AL, Gaulard P, Miranda RN, et al
    Reply to M. Romero et al.
    J Clin Oncol. 2020;38:2819-2820.

  74. KURIAN AW, Ward KC, Abrahamse P, Bondarenko I, et al
    Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019.
    J Clin Oncol. 2021 Feb 9:JCO2002785. doi: 10.1200/JCO.20.02785.
    PubMed         Abstract available

    J Surg Oncol

  75. SANTIAGO L, Volk RJ, Checka CM, Black D, et al
    Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study.
    J Surg Oncol. 2021 Feb 12. doi: 10.1002/jso.26420.
    PubMed         Abstract available

    Lancet Oncol

  76. POORTMANS PM, Weltens C, Kirkove C
    Indications for individual internal mammary node irradiation - Authors' reply.
    Lancet Oncol. 2021;22:e41.

  77. RYZHOV A, Corbex M, Pineros M, Barchuk A, et al
    Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.
    Lancet Oncol. 2021 Feb 5. pii: S1470-2045(20)30674.
    PubMed         Abstract available

  78. QIU PF, Wang XE, Wang YS
    Indications for individual internal mammary node irradiation.
    Lancet Oncol. 2021;22:e40.

    Mod Pathol

  79. SLEMBROUCK L, Vanden Bempt I, Wildiers H, Smeets A, et al
    Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.
    Mod Pathol. 2021 Feb 8. pii: 10.1038/s41379-021-00743.
    PubMed         Abstract available

    Nat Rev Clin Oncol

    Neoadjuvant therapy improves pCR rate.
    Nat Rev Clin Oncol. 2020;17:718.

    NPJ Breast Cancer

  81. LARSSON C, Ehinger A, Winslow S, Leandersson K, et al
    Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer.
    NPJ Breast Cancer. 2020;6:28.
    PubMed         Abstract available

  82. WANG K, Sun JZ, Wu QX, Li ZY, et al
    Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study.
    NPJ Breast Cancer. 2020;6:36.
    PubMed         Abstract available

  83. JENSEN MB, Laenkholm AV, Balslev E, Buckingham W, et al
    The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients.
    NPJ Breast Cancer. 2020;6:7.
    PubMed         Abstract available

  84. KOS Z, Roblin E, Kim RS, Michiels S, et al
    Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
    NPJ Breast Cancer. 2020;6:17.
    PubMed         Abstract available

  85. ROELANDS J, Mall R, Almeer H, Thomas R, et al
    Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry.
    NPJ Breast Cancer. 2021;7:10.
    PubMed         Abstract available

  86. KHAN KA, Ponce de Leon JL, Benguigui M, Xu P, et al
    Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.
    NPJ Breast Cancer. 2020;6:29.
    PubMed         Abstract available

  87. COSTA RLB, Czerniecki BJ
    Clinical development of immunotherapies for HER2(+) breast cancer: a review of HER2-directed monoclonal antibodies and beyond.
    NPJ Breast Cancer. 2020;6:10.
    PubMed         Abstract available

  88. GADALETA E, Fourgoux P, Pirro S, Thorn GJ, et al
    Characterization of four subtypes in morphologically normal tissue excised proximal and distal to breast cancer.
    NPJ Breast Cancer. 2020;6:38.
    PubMed         Abstract available

  89. WILSON HE, Stanton DA, Montgomery C, Infante AM, et al
    Skeletal muscle reprogramming by breast cancer regardless of treatment history or tumor molecular subtype.
    NPJ Breast Cancer. 2020;6:18.
    PubMed         Abstract available

  90. FOLDI J, Silber A, Reisenbichler E, Singh K, et al
    Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
    NPJ Breast Cancer. 2021;7:9.
    PubMed         Abstract available

  91. ETHIER SP, Guest ST, Garrett-Mayer E, Armeson K, et al
    Development and implementation of the SUM breast cancer cell line functional genomics knowledge base.
    NPJ Breast Cancer. 2020;6:30.
    PubMed         Abstract available


  92. WANG G, Wang J, Chang A, Cheng D, et al
    Correction to: Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2.
    Oncogene. 2021 Feb 10. pii: 10.1038/s41388-021-01652.

  93. KUNG CP, Cottrell KA, Ryu S, Bramel ER, et al
    Correction to: Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer.
    Oncogene. 2021 Feb 9. pii: 10.1038/s41388-021-01669.

    Oncology (Williston Park)

  94. LAWS A, Garrido-Castro A, Poorvu P, Winer E, et al
    Utility of the 21-Gene Recurrence Score in Node-Positive Breast Cancer.
    Oncology (Williston Park). 2021;35:77-84.
    PubMed         Abstract available

    PLoS Comput Biol

  95. BEN-ELAZAR S, Aure MR, Jonsdottir K, Leivonen SK, et al
    miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer.
    PLoS Comput Biol. 2021;17:e1008608.
    PubMed         Abstract available

    PLoS One

  96. SCIMONE MT, Krishnamurthy S, Maguluri G, Preda D, et al
    Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study.
    PLoS One. 2021;16:e0245334.
    PubMed         Abstract available

  97. JACKSON C, Freeman ALJ, Szlamka Z, Spiegelhalter DJ, et al
    The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
    PLoS One. 2021;16:e0246441.
    PubMed         Abstract available

  98. PHAM DX, Ho TH, Bui TD, Ho-Pham LT, et al
    Trends in breast cancer incidence in Ho Chi Minh City 1996-2015: A registry-based study.
    PLoS One. 2021;16:e0246800.
    PubMed         Abstract available

  99. ASADI M, Ahmadi N, Ahmadvand S, Jafari AA, et al
    Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker.
    PLoS One. 2021;16:e0246752.
    PubMed         Abstract available

  100. YANAI H, Yoshikawa K, Ishida M, Tsuta K, et al
    Presence of myxoid stromal change and fibrotic focus in pathological examination are prognostic factors of triple-negative breast cancer: Results from a retrospective single-center study.
    PLoS One. 2021;16:e0245725.
    PubMed         Abstract available

  101. ZHANG H, Zhang LQ, Yang CC, Li J, et al
    The high expression of NUDT5 indicates poor prognosis of breast cancer by modulating AKT / Cyclin D signaling.
    PLoS One. 2021;16:e0245876.
    PubMed         Abstract available

  102. BAR H, Bang S
    A mixture model to detect edges in sparse co-expression graphs with an application for comparing breast cancer subtypes.
    PLoS One. 2021;16:e0246945.
    PubMed         Abstract available

  103. HONG JH, Goo JM, Moon HG, Chang JM, et al
    Usefulness of staging chest-CT in patients with operable breast cancer.
    PLoS One. 2021;16:e0246563.
    PubMed         Abstract available

    Proc Natl Acad Sci U S A

  104. SURESH BM, Li W, Zhang P, Wang KW, et al
    A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.
    Proc Natl Acad Sci U S A. 2020;117:33197-33203.
    PubMed         Abstract available

  105. GAO Y, Chen X, He Q, Gimple RC, et al
    Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
    Proc Natl Acad Sci U S A. 2020;117:33295-33304.
    PubMed         Abstract available

    Radiol Imaging Cancer

  106. MANKOFF DA, Surti S
    PET/MRI for Primary Breast Cancer: A Match Made Better by PET Quantification?
    Radiol Imaging Cancer. 2021;3:e200150.

  107. FOWLER AM, Kumar M, Bancroft LH, Salem K, et al
    Measuring Glucose Uptake in Primary Invasive Breast Cancer Using Simultaneous Time-of-Flight Breast PET/MRI: A Method Comparison Study with Prone PET/CT.
    Radiol Imaging Cancer. 2021;3:e200091.
    PubMed         Abstract available


  108. HENDRICK RE, Helvie MA, Monticciolo DL
    Breast Cancer Mortality Rates Have Stopped Declining in U.S. Women Younger than 40 Years.
    Radiology. 2021 Feb 9:203476. doi: 10.1148/radiol.2021203476.
    PubMed         Abstract available

  109. HARADA TL, Uematsu T, Nakashima K, Kawabata T, et al
    Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing Occult Inflammatory Breast Cancer and Can Predict Prognosis after Neoadjuvant Chemotherapy.
    Radiology. 2021 Feb 9:202604. doi: 10.1148/radiol.2021202604.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.